Related Experiment Video
Updated: Jun 3, 2026
Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
Functional evaluation and clinical classification of BRCA2 variants.
Huaizhi Huang1,2,3, Chunling Hu4, Jie Na5
1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Functional characterization of BRCA2 variants using CRISPR-Cas9 technology improves cancer risk assessment. This study classified 91% of BRCA2 variants, aiding clinical management for patients with genetic testing results.
Area of Science:
- Genetics and genomics
- Cancer biology
- Molecular diagnostics
Background:
- Germline BRCA2 loss-of-function variants increase cancer predisposition.
- Variants of uncertain significance (VUS) hinder clinical utility of genetic testing.
- Functional characterization is crucial for classifying all BRCA2 variants.
Purpose of the Study:
- To functionally characterize single-nucleotide variants in the BRCA2 DNA-binding domain.
- To classify BRCA2 variants for improved clinical management.
- To assess the association of BRCA2 variants with cancer risk.
Main Methods:
- Utilized saturation genome editing with CRISPR-Cas9 in HAP1 cells.
- Analyzed single-nucleotide variants in BRCA2 exons 15-26.
- Employed a VarCall Bayesian model for pathogenicity categorization.
Main Results:
- 6,959 out of 6,960 variants were evaluated and assigned pathogenicity categories.
- Loss-of-function missense variants in BRCA2 correlate with increased breast and ovarian cancer risks.
- 91% of variants were classified as pathogenic, likely pathogenic, benign, or likely benign.
Conclusions:
- This functional assay approach enables robust classification of BRCA2 variants.
- Classified variants enhance clinical decision-making for individuals undergoing genetic testing.
- Improved classification of BRCA2 variants aids in managing hereditary cancer risks.
More Related Videos
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
09:22Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
Published on: February 28, 2021
Related Concept Videos
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...